Anthem Biosciences Limited — Others, 13-08-2025: Shareholders meeting

Anthem Biosciences is seeking shareholder approval via postal ballot for key strategic proposals. The company proposes to ratify its Employee Stock Option Plan 2024, designed to incentivize talent, allowing for up to 1.14 Cr ESOPs, and extend its benefits to subsidiary employees. Additionally, shareholders will vote on remuneration for two related parties for FY25-26: Ishaan Bhardwaj, VP (son of MD & CEO), at ₹1.20 Cr annually for expanded responsibilities in CRDMO procurement, and Krithika Ganesh, Deputy Manager (daughter of WTD), at ₹0.31 Cr annually for new project management roles. These moves aim to align employee interests with growth and ensure transparent compensation. Related parties will abstain from voting on remuneration.